SMS Pharmaceuticals informs about outcome of board meeting
SMS Pharmaceuticals has informed that the Board of Directors of the Company at their meeting held today, 1 st July, 2025, has transacted and approved the following item(s) of the Agenda: Approved the Re-appointment of Vamsi Krishna Potluri (DIN:06956498) as Whole Time Director of the Company designated as an Executive Director with effect from 01st July, 2025 for a period of 3 (three) years, subject to the approval of the shareholders at the ensuring general meeting of the Company. Further, Vamsi Krishna Potluri is not debarred from holding the office of Director by virtue of any Order passed by the Securities and Exchange Board of India or any other such authority. The details required to be furnished under SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 November 11, 2024 is annexed herewith as Annexure-I The meeting commenced at 4:00 pm and concluded at about 4.40 pm.
The above information is a part of company’s filings submitted to BSE.
